This article reviews the glucagon-like peptide 1 (GLP-1) agonistbased therapies as a new class of antidiabetic and their potential effects beyond glucose control that may ultimately impact cardiovascular disease
It is studied because it gives researchers a way to examine coordinated repair-associated signalling across multiple tissue models
Clinical trials show an average weight loss of about 15% of body weight over 68 weeks
Intended User: Primary: Registered dietitians or nutrition professionals working with clients on GLP-1 medications such as Ozempic, Wegovy, Mounjaro, or Zepbound Secondary: Individuals taking GLP-1s looking for guidance on food choices, meal planning, and easy meal/snack ideas Whats Included: Page 1: GLP-1 Grocery List A clean, easy-to-read, client-friendly shopping list broken into categories like produce, proteins (including plant-based options), grains, and pantry staples
ROS was visualised with using DCFH-DA, a non-specific redox probe that emits green fluorescence in the presence of any type of ROS